Our highly qualified team is led by world-renowned fertility experts Professor Ovrang Djahanbakhch, Mr Michael Summers, Mrs Shailaja Nair, Mr Julian Mamiso, Dr Vivienne Hall and Professor Alan Handyside.
Michael C. Summers MD PhD FACOG
Consultant in Reproductive Medicine
A graduate of King’s College, Cambridge Mr Summers completed his medical training at the University of Pennsylvania School of Medicine followed by a Clinical Fellowship in Reproductive Endocrinology and Infertility at the Brigham and Women’s Hospital, Harvard Medical School. He is certified by both the American College of Obstetrics and Gynaecology (ACOG) as well as on the GMC Specialist Register as a Consultant in Reproductive Medicine. His special interests include IVF, embryo culture, embryo implantation and preimplantation genetic diagnostics, areas of research in which he has published extensively.
Shailaja Nair MD FRCOG
Deputy Clinical Director
Shailaja Nair is Deputy Clinical Director of the Bridge Centre and has more than 20 years experience in fertility and assisted reproduction. Dr Nair has worked at the LWC since 1993 and now splits her time between the LWC and Bridge Centre. Before joining the LWC, she worked as Associate Professor in a large teaching hospital and at the Cromwell IVF programme before joining the LWC in 1993. Dr Nair has extensive experience in all aspects of assisted conception, with a special interest in the egg-sharing and gamete donation programmes.
Consultant Gynaecologist and IVF Specialist
Julian Mamiso, Consultant Gynaecologist & Fertility Specialist, obtained his medical degree in 1978 from the University of Ibadan in Nigeria. He enrolled for postgraduate training with the Royal College Of Obstetricians and Gynaecologists UK and obtained MRCOG in 1986, becoming a Fellow of the college in 2000. Dr Mamiso trained in assisted conception at the University of Sheffield under Professor Ian Cooke. Since then he has worked for the LWC group in Swansea 1995-1997, LWC Darlington 2003-2006, and now LWC Swansea and Cardiff.
Vivienne Hall MB, BS, FRCOG
Dr Hall qualified at St Bartholomew's Hospital, London In 1982. She trained in general obstetrics and gynaecology in London and obtained MRCOG in 1990. Dr Hall specialised in infertility at Hammersmith Hospital until 1994 when she moved to Italy spending 12 years establishing and directing 2 successful IVF units in Milan and Turin.
Since returning to the UK she has worked in private units and the NHS and now practices general obstetrics and gynaecology as well as infertility. Her special areas of interest are egg and embryo donation and nutrition. She is particularly experienced in dietary management of PCOS and insulin resistance and fertility and assisted conception.
Clinical Research Fellow
Julija Gorodeckaja is a clinical research fellow at the Bridge Centre. She trained at Vilnius University Hospital in the Obstetrics and Gynaecology Department. Since moving to the UK in 2012, she has worked at the Whittington Hospital as a specialist trainee, at the Baltic Medical Centre and at the Kings College Hospital as a Clinical Fellow. Her specialist interests are in early pregnancy diagnostics and infertility diagnostics.
Ovrang Djahanbakhch MD, FRCOG
Chairman of Medical Advisory Committee
Professor Djahanbakhch is a founder of the Bridge Centre, a distinguished Professor of Reproductive Medicine at the University of London and Chairman of the Medical Advisory Committee at the Bridge Centre. His distinguised work has earned him much recognition.
Scientific & Managing Director
Kamal Ahuja gained his PhD at Cambridge under the supervision of Professor Robert Edwards, which sparked his lasting interest in clinical IVF. The ethics of IVF and its cost effectiveness continue to be part of his research interests. Dr Ahuja is Chairman of Reproductive BioMedicine Online, an international medical journal, and the Scientific and Managing Director of the London Women's Clinic Group.
Peter Bowen-Simpkins is a Consultant Gynaecologist and Medical Director of the London Women’s Clinic Group. He qualified from Cambridge University and Guy’s Hospital Medical School and obtained the Hancock Prize for Surgery from the Royal College of Surgeons. After completing his training in London, he was appointed to a consultant post in Swansea. His main interests have been fertility, the menopause and menstrual disorders. He was on the Council of the Royal College of Obstetricians and Gynaecologists for 13 years, the latter seven as the Honorary Treasurer. He is a Trustee of Wellbeing of Women and is a spokesman for both the College and the charity. He is a regular broadcaster and lectures all over the UK and abroad. Currently he is also the Honorable Treasurer of the Royal Medical Benevolent Fund.
Alan Handyside MA PhD
Consultant in Pre-implantation Genetics
Professor Handyside is a leading scientist in human embryology and the genetics of early human development having pioneered the development of Preimplantation Genetic Diagnosis (PGD) and Genetic Embryo Testing for chromosome aneuploidy - two groundbreaking techniques for identifying genetic abnormality and for assisting embryo selection which, are both available at the Bridge Centre.
Professor Handyside supports the Bridge team in all aspects of patient care and continues to lead important developments in embryo assessment.
Sue has been involved in the field of fertility for 20 years and is both a Registered Nurse and Midwife. She has worked in both the NHS and private sectors and is passionate about providing excellent care to all those seeking advice and treatment. Before joining the Bridge Centre she worked at the Assisted Conception Unit at Guy’s hospital, London.
Jinjun Wang is a senior embryologist and lab manager at the LWC. He received his embryology training from Shenzen Hospital of Beijing University and Sydney and worked steadfastly to enhance his skills between 2005-2008 before joining the London Women’s Clinic in 2008. Early in 2013 he was recognised with the position of Laboratory Manager with the objective of maintaining the high success rate of the laboratory and introducing new technologies such as oocyte vitrification and blastomere biopsy for the benefit of the LWC patients.